Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS trial_result · 2016-01-22
  Clinical Trial Update: Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia [Phase 2]

  This clinical trial update reports long-term safety data for dasatinib in patients with chronic myeloid leukemia and Philadelphia chromosome…

• CLINICAL_TRIALS trial_result · 2015-09-18
  Clinical Trial Update: Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia [Phase 2]

  A Phase 2 study evaluating Hyper-CVAD plus Imatinib Mesylate for Philadelphia chromosome-positive acute lymphoblastic leukemia; results were…

• CLINICAL_TRIALS trial_result · 2015-08-21
  Clinical Trial Update: Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia [Phase 1]

  Clinical trial update for XL228 in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia; the Phase 1 s…

• CLINICAL_TRIALS trial_result · 2015-05-29
  Clinical Trial Update: First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL [Phase 2]

  Phase 2 trial evaluating first-line dasatinib in combination with conventional chemotherapy for adults with Philadelphia chromosome-positive…

• CLINICAL_TRIALS trial_result · 2015-01-30
  Clinical Trial Update: A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED) [Phase 1]

  A Phase I dose-escalation combination study in patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblast…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-01-26
  Clinical Trial Update: A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008) [Phase 2]

  Phase II trial of MK0457 in T315I-mutant chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia was term…

• CLINICAL_TRIALS trial_result · 2014-10-22
  Clinical Trial Update: Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML [Phase 3]

  This is a Phase 3 clinical trial update for dasatinib (BMS-354825) in chronic myeloid leukemia; the study is completed and results were post…

• CLINICAL_TRIALS trial_result · 2014-04-10
  Clinical Trial Update: Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia [Phase 1]

  Phase 1 trial evaluating induction therapy with cytarabine, high-dose mitoxantrone, and dasatinib for Philadelphia chromosome-positive acute…

• CLINICAL_TRIALS trial_result · 2013-06-05
  Clinical Trial Update: Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

  A completed Phase 1/2 trial evaluated arsenic trioxide in combination with imatinib mesylate for patients with accelerated-phase or blast-ph…

• CLINICAL_TRIALS trial_result · 2012-03-13
  Clinical Trial Update: Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. [Phase 1]

  A pediatric pharmacokinetic study of Glivec/Gleevec (imatinib) in children aged 1 to less than 4 with chronic myeloid leukemia, Philadelphia…

• CLINICAL_TRIALS trial_result · 2011-10-05
  Clinical Trial Update: Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive [Phase 2]

  Phase 2 trial evaluating imatinib mesylate in combination with vincristine and dexamethasone for Philadelphia chromosome-positive acute lymp…

• CLINICAL_TRIALS trial_result · 2011-04-19
  Clinical Trial Update: Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study [Phase 1]

  Phase 1 trial conducted by Bristol-Myers Squibb in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemi…

• CLINICAL_TRIALS trial_result · 2010-12-14
  Clinical Trial Update: Rollover Study of BMS-354825 in Patients With CML and Ph+ALL [Phase 1, Phase 2]

  Rollover study of BMS-354825 (dasatinib) in patients with chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblas…

• CLINICAL_TRIALS trial_result · 2010-01-05
  Clinical Trial Update: LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive [Phase 4]

  This clinical trial update notes the completion of the Phase 4 study LAL-Ph-2000 evaluating treatment for Philadelphia chromosome-positive a…

• CLINICAL_TRIALS trial_result · 2008-11-19
  Clinical Trial Update: Glivec in Ph Positive Lymphoblastic Leukemia [Phase 2]

  Phase 2 trial update of Glivec (imatinib) in Philadelphia chromosome-positive acute lymphoblastic leukemia; the study status is COMPLETED.

• CLINICAL_TRIALS trial_result · 2007-04-27
  Clinical Trial Update: Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. [Phase 2]

  Phase 2 trial evaluating Imatinib Mesylate in combination with chemotherapy for elderly patients with Philadelphia chromosome-positive acute…